Michael R. Kilbourn - Publications

Affiliations: 
Radiology University of Michigan Medical School, Ann Arbor, MI, United States 
Area:
PET neuroimaging, Parkinson's disease, PET radiochemistry
Website:
http://www2.med.umich.edu/pcdv2/provider/dsp_provprofile.cfm?individual_id=143674&um_department=Radiology

213 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Brooks AF, Mufarreh AJ, Shao X, Kaur T, Stauff J, Arteaga J, Kilbourn MR, Scott PJH. Improved Synthesis of [C]COU and [C]PHXY, Evaluation of Neurotoxicity, and Imaging of MAOs in Rodent Heart. Acs Medicinal Chemistry Letters. 11: 2300-2304. PMID 33214844 DOI: 10.1021/Acsmedchemlett.0C00419  0.681
2020 Murrell E, Pham JM, Sowa AR, Brooks AF, Kilbourn MR, Scott PJH, Vasdev N. Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic Pathway. Acs Chemical Neuroscience. PMID 32578977 DOI: 10.1021/Acschemneuro.0C00343  0.793
2020 Kilbourn MR, Cole EL, Scott PJH. In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain. Nuclear Medicine and Biology. PMID 32122751 DOI: 10.1016/J.Nucmedbio.2020.02.008  0.445
2019 Drake LR, Pham JM, Desmond TJ, Mossine AV, Lee SJ, Kilbourn MR, Koeppe RA, Brooks AF, Scott PJH. Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase. Acs Chemical Neuroscience. PMID 31339297 DOI: 10.1021/Acschemneuro.9B00326  0.819
2019 Narayanaswami V, Drake LR, Brooks AF, Meyer JH, Houle S, Kilbourn MR, Scott PJH, Vasdev N. Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases. Acs Chemical Neuroscience. PMID 30789704 DOI: 10.1021/Acschemneuro.9B00081  0.797
2018 Brooks AF, Drake LR, Shao X, Zhao A, Scott PJH, Kilbourn MR. Evaluation of Enzyme Substrate Radiotracers as PET/MRS Hybrid Imaging Agents. Acs Medicinal Chemistry Letters. 9: 1140-1143. PMID 30429959 DOI: 10.1021/Acsmedchemlett.8B00402  0.792
2018 Kilbourn MR, Koeppe RA. Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2. Acs Chemical Neuroscience. 10: 25-29. PMID 30198706 DOI: 10.1021/Acschemneuro.8B00429  0.435
2018 Drake LR, Brooks AF, Mufarreh AJ, Pham JM, Koeppe RA, Shao X, Scott PJH, Kilbourn MR. Deuterium Kinetic Isotope Effect Studies of a Potential In Vivo Metabolic Trapping Agent for Monoamine Oxidase-B. Acs Chemical Neuroscience. PMID 30074755 DOI: 10.1021/Acschemneuro.8B00219  0.81
2018 Sowa AR, Brooks AF, Shao X, Henderson BD, Sherman PS, Arteaga J, Stauff J, Lee AC, Koeppe RA, Scott PJH, Kilbourn MR. Development of Positron Emission Tomography (PET) Radiotracers for the GABA Transporter 1 (GAT-1). Acs Chemical Neuroscience. PMID 29763549 DOI: 10.1021/Acschemneuro.8B00183  0.824
2017 Kilbourn MR, Koeppe RA. A six-year longitudinal PET study of (+)-[C]DTBZ binding to the VMAT2 in monkey brain. Nuclear Medicine and Biology. 55: 34-37. PMID 29031997 DOI: 10.1016/J.Nucmedbio.2017.08.008  0.46
2017 Kilbourn MR. Small Molecule PET Tracers for Transporter Imaging. Seminars in Nuclear Medicine. 47: 536-552. PMID 28826525 DOI: 10.1053/J.Semnuclmed.2017.05.005  0.383
2017 Blecha JE, Henderson BD, Hockley BG, VanBrocklin HF, Zubieta JK, DaSilva AF, Kilbourn MR, Koeppe RA, Scott PJH, Shao X. An Updated Synthesis of [(11) C]Carfentanil for Positron Emission Tomography (PET) Imaging of the μ-Opioid Receptor. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28419528 DOI: 10.1002/Jlcr.3513  0.675
2016 Kilbourn MR. PET studies in non-human primates: Choosing drug doses. Nuclear Medicine and Biology. 47: 1-3. PMID 28012346 DOI: 10.1016/J.Nucmedbio.2016.12.001  0.301
2016 Thompson S, Kilbourn MR, Scott PJ. Radiochemistry, PET Imaging, and the Internet of Chemical Things. Acs Central Science. 2: 497-505. PMID 27610410 DOI: 10.1021/Acscentsci.6B00178  0.559
2016 Scott PJ, Shao X, Desmond TJ, Hockley BG, Sherman P, Quesada CA, Frey KA, Koeppe RA, Kilbourn MR, Bohnen NI. Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. Acs Medicinal Chemistry Letters. 7: 746-50. PMID 27563397 DOI: 10.1021/Acsmedchemlett.5B00435  0.741
2015 Brooks AF, Shao X, Quesada CA, Sherman P, Scott PJ, Kilbourn MR. In Vivo Metabolic Trapping Radiotracers for Imaging Monoamine Oxidase-A and -B Enzymatic Activity. Acs Chemical Neuroscience. PMID 26393369 DOI: 10.1021/Acschemneuro.5B00223  0.753
2014 Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. Acs Chemical Neuroscience. 5: 718-30. PMID 24896980 DOI: 10.1021/Cn500103U  0.82
2014 Rodnick ME, Shao X, Kozloff KM, Scott PJ, Kilbourn MR. Carbon-11 labeled cathepsin K inhibitors: syntheses and preliminary in vivo evaluation. Nuclear Medicine and Biology. 41: 384-9. PMID 24637099 DOI: 10.1016/J.Nucmedbio.2014.02.004  0.766
2014 Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/Jnumed.113.124792  0.654
2013 Kilbourn MR. PET radioligands for the vesicular transporters for monoamines and acetylcholine Journal of Labelled Compounds and Radiopharmaceuticals. 56: 167-171. PMID 24285322 DOI: 10.1002/Jlcr.2998  0.347
2013 Hockley BG, Stewart MN, Sherman P, Quesada C, Kilbourn MR, Albin RL, Scott PJ. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 595-9. PMID 24285235 DOI: 10.1002/Jlcr.3069  0.821
2013 Rodnick ME, Hockley BG, Sherman P, Quesada C, Battle MR, Jackson A, Linder KE, Macholl S, Trigg WJ, Kilbourn MR, Scott PJH. Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain Nuclear Medicine and Biology. 40: 901-905. PMID 23890694 DOI: 10.1016/J.Nucmedbio.2013.06.004  0.842
2012 Shao X, Carpenter GM, Desmond TJ, Sherman P, Quesada CA, Fawaz M, Brooks AF, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. Acs Medicinal Chemistry Letters. 3: 936-41. PMID 24900410 DOI: 10.1021/Ml300216T  0.766
2012 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/Jcbfm.2012.60  0.306
2011 Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/Brain/Awr089  0.317
2011 Kilbourn MR, Domino EF. Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats. European Journal of Pharmacology. 654: 254-7. PMID 21262223 DOI: 10.1016/J.Ejphar.2011.01.008  0.317
2011 Gilman S, Giordani B, Albin R, Koeppe R, Burke J, Kilbourn M, Frey K. Mild Dementia evaluated with [11C]DTBZ and [11C]PiB positron emission tomography Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.277  0.356
2010 Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM. (18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons. Pet Clinics. 5: 75-82. PMID 27157484 DOI: 10.1016/J.Cpet.2010.02.001  0.321
2010 Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nuclear Medicine and Biology. 37: 989-96. PMID 21055630 DOI: 10.1016/J.Nucmedbio.2010.06.002  0.81
2010 Kilbourn MR. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers Nuclear Medicine and Biology. 37: 869-871. PMID 21055616 DOI: 10.1016/J.Nucmedbio.2010.06.001  0.362
2010 Coenen HH, Elsinga PH, Iwata R, Kilbourn MR, Pillai MR, Rajan MG, Wagner HN, Zaknun JJ. Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences. Nuclear Medicine and Biology. 37: 727-40. PMID 20870148 DOI: 10.1016/J.Nucmedbio.2010.04.185  0.421
2010 Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/Archneurol.2010.34  0.392
2010 Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations Nuclear Medicine and Biology. 37: 3-8. PMID 20122661 DOI: 10.1016/J.Nucmedbio.2009.08.013  0.376
2010 Kilbourn M, Sherman P, Quesada C, Vartak A, Crooks P, Dwoskin L. Effects of a lobelane analog on [11C]DTBZ binding to the VMAT2 Neuroimage. 52: S68. DOI: 10.1016/J.Neuroimage.2010.04.053  0.337
2010 Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM. 18F-AV-133: A selective VMAT2-binding radiopharmaceutical for PET imaging of dopaminergic neurons Pet Clinics. 5: 75-82. DOI: 10.1016/j.cpet.2010.02.001  0.309
2009 Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1887-94. PMID 19837759 DOI: 10.2967/Jnumed.109.065284  0.434
2009 Kilbourn MR, Hockley B, Lee L, Sherman P, Quesada C, Frey KA, Koeppe RA. Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter Nuclear Medicine and Biology. 36: 489-493. PMID 19520289 DOI: 10.1016/J.Nucmedbio.2009.02.007  0.811
2009 Joshi AD, Koeppe RA, Fessler JA, Kilbourn MR. Signal separation and parameter estimation in noninvasive dual-tracer PET scans using reference-region approaches Journal of Cerebral Blood Flow and Metabolism. 29: 1346-1357. PMID 19401708 DOI: 10.1038/Jcbfm.2009.53  0.39
2009 Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/Wnl.0B013E3181A187Dd  0.33
2009 Shao X, Kilbourn MR. A simple modification of GE tracerlab FX C Pro for rapid sequential preparation of [11C]carfentanil and [11C]raclopride Applied Radiation and Isotopes. 67: 602-605. PMID 19162491 DOI: 10.1016/J.Apradiso.2008.12.013  0.627
2009 Scott PJ, Hockley BG, Kung HF, Manchanda R, Zhang W, Kilbourn MR. Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: 88-94. PMID 18951032 DOI: 10.1016/J.Apradiso.2008.08.015  0.595
2008 Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nuclear Medicine and Biology. 35: 825-37. PMID 19026944 DOI: 10.1016/J.Nucmedbio.2008.08.004  0.453
2008 Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4′-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands Nuclear Medicine and Biology. 35: 549-559. PMID 18589299 DOI: 10.1016/J.Nucmedbio.2007.08.003  0.83
2008 Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF. In vivo imaging of β-cell mass in rats using 18F-FP-(+)- DTBZ: A potential PET ligand for studying diabetes mellitus Journal of Nuclear Medicine. 49: 1171-1176. PMID 18552132 DOI: 10.2967/Jnumed.108.051680  0.442
2008 Kilbourn MR, Butch E, Desmond T, Sherman P, Frey K. Dopamine depletion increases in vivo [11C]DTBZ binding in awake rat brain Neuroimage. 41: T54. DOI: 10.1016/J.Neuroimage.2008.04.228  0.378
2008 Kilbourn MR, Donnelly D, Husbands S, Greedy B, Woods J, Traynor J. Synthesis and in vivo PET imaging studies with [11C]BU4033, a potential delta opioid imaging agent Neuroimage. 41: T23. DOI: 10.1016/J.Neuroimage.2008.04.197  0.548
2008 Kilbourn MR, Domino E. In vivo [11C]raclopride binding in amphetamine-sensitized rat brain Neuroimage. 41: T127. DOI: 10.1016/J.Neuroimage.2008.04.095  0.383
2008 Kilbourn MR, Hockley B, Lee L, Koeppe R. Successful [18F]FEOBV imaging of the VAChT in monkey brain Neuroimage. 41: T93. DOI: 10.1016/J.Neuroimage.2008.04.062  0.445
2007 Kilbourn MR, Ma B, Butch ER, Quesada C, Sherman PS. Anesthesia increases in vivo N-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor Nuclear Medicine and Biology. 34: 479-482. PMID 17591547 DOI: 10.1016/J.Nucmedbio.2007.04.008  0.615
2007 Scott PJH, Kilbourn MR. Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use Applied Radiation and Isotopes. 65: 1359-1362. PMID 17582776 DOI: 10.1016/J.Apradiso.2007.04.020  0.415
2007 Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters Nuclear Medicine and Biology. 34: 239-246. PMID 17383573 DOI: 10.1016/J.Nucmedbio.2006.12.005  0.465
2007 Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP, Kung HF. Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain Nuclear Medicine and Biology. 34: 233-237. PMID 17383572 DOI: 10.1016/J.Nucmedbio.2007.01.007  0.815
2007 Kilbourn M, Hockley B, Lee L, Hou C, Goswami R, Ponde D, Kung MP, Kung H. Fluorine-18 labeled dihydrotetrabenazine (DTBZ) derivatives for PET imaging of VMAT2 in the brain Journal of Cerebral Blood Flow and Metabolism. 27: PP10-06U.  0.336
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Imaging butyrylcholinesterase activity in Alzheimer's disease. Annals of Neurology. 60: 746. PMID 17192935 DOI: 10.1002/Ana.21023  0.491
2006 Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters Nuclear Medicine and Biology. 33: 685-694. PMID 16934687 DOI: 10.1016/J.Nucmedbio.2006.05.006  0.394
2006 Souza F, Simpson N, Raffo A, Saxena C, Maffei A, Hardy M, Kilbourn M, Goland R, Leibel R, Mann JJ, Van Heertum R, Harris PE. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. The Journal of Clinical Investigation. 116: 1506-13. PMID 16710474 DOI: 10.1172/Jci27645  0.345
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/Ana.20672  0.569
2005 Ma B, Hankenson KD, Dennis JE, Caplan AI, Goldstein SA, Kilbourn MR. A simple method for stem cell labeling with fluorine 18 Nuclear Medicine and Biology. 32: 701-705. PMID 16243645 DOI: 10.1016/J.Nucmedbio.2005.04.018  0.594
2005 Nabulsi NB, Smith DE, Kilbourn MR. [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice. Bioorganic & Medicinal Chemistry. 13: 2993-3001. PMID 15781409 DOI: 10.1016/J.Bmc.2005.02.002  0.608
2005 Shao X, Koeppe RA, Butch ER, Kilbourn MR, Snyder SE. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers Bioorganic and Medicinal Chemistry. 13: 869-875. PMID 15653352 DOI: 10.1016/J.Bmc.2004.10.034  0.775
2004 Parrott AC, Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. MDMA and the loss of reinforcement in Fantegrossi et al (2004) (multiple letters) Neuropsychopharmacology. 29: 1940-1942. PMID 15383828 DOI: 10.1038/Sj.Npp.1300538  0.621
2004 Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain Experimental Neurology. 188: 387-390. PMID 15246838 DOI: 10.1016/J.Expneurol.2004.05.001  0.364
2004 Kilbourn MR. Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain Nuclear Medicine and Biology. 31: 591-595. PMID 15219277 DOI: 10.1016/J.Nucmedbio.2004.02.003  0.365
2004 Ma B, Sherman PS, Moskwa JE, Koeppe RA, Kilbourn MR. Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([ 11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods Nuclear Medicine and Biology. 31: 393-397. PMID 15093808 DOI: 10.1016/J.Nucmedbio.2003.12.009  0.633
2004 Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1270-81. PMID 15039771 DOI: 10.1038/Sj.Npp.1300442  0.688
2004 Jewett DM, Kilbourn MR. In vivo evaluation of new carfentanil-based radioligands for the mu opiate receptor Nuclear Medicine and Biology. 31: 321-325. PMID 15028244 DOI: 10.1016/J.Nucmedbio.2003.10.009  0.436
2004 Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004) Neuropsychopharmacology. 29: 1942-1942. DOI: 10.1038/Sj.Npp.1300539  0.621
2003 Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189 DOI: 10.1212/01.Wnl.0000076181.39162.Fc  0.347
2003 Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2000-9. PMID 12902992 DOI: 10.1038/Sj.Npp.1300251  0.46
2003 Shao X, Butch ER, Kilbourn MR, Snyder SE. N-[18F]fluoroethylpiperidinyl, N-[18F]fluoroethylpiperidinemethyl and N-[18F]fluoroethylpyrrolidinyl esters as radiotracers for acetylcholinesterase Nuclear Medicine and Biology. 30: 491-500. PMID 12831986 DOI: 10.1016/S0969-8051(03)00031-3  0.748
2003 Shao X, Lisi JM, Butch ER, Kilbourn MR, Snyder SE. N-methylpiperidinemethyl, N-methylpyrrolidyl and N-methylpyrrolidinemethyl esters as PET radiotracers for acetylcholinesterase activity Nuclear Medicine and Biology. 30: 293-302. PMID 12745021 DOI: 10.1016/S0969-8051(02)00438-9  0.727
2002 Skaddan MB, Jewett DM, Sherman PS, Kilbourn MR. (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor Synapse. 45: 31-37. PMID 12112411 DOI: 10.1002/Syn.10079  0.789
2002 Kilbourn MR, Sherman PS, Kuszpit K. In vivo measures of dopaminergic radioligands in the rat brain: Equilibrium infusion studies Synapse. 43: 188-194. PMID 11793424 DOI: 10.1002/Syn.10039  0.41
2002 Jewett DM, Kilbourn MR. A convenient synthesis of [11C]paraquat and other [N-methyl-11C]bisquaternary ammonium compounds Journal of Labelled Compounds and Radiopharmaceuticals. 45: 281-289. DOI: 10.1002/Jlcr.564  0.35
2001 Koeppe RA, Raffel DM, Snyder SE, Ficaro EP, Kilbourn MR, Kuhl DE. Dual-[11C]tracer single-acquisition positron emission tomography studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 1480-92. PMID 11740210 DOI: 10.1097/00004647-200112000-00013  0.408
2001 Skaddan MB, Sherman PS, Kilbourn MR. The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligands Nuclear Medicine and Biology. 28: 753-759. PMID 11578895 DOI: 10.1016/S0969-8051(01)00240-2  0.784
2001 Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors Journal of Cerebral Blood Flow and Metabolism. 21: 144-148. PMID 11176279 DOI: 10.1097/00004647-200102000-00005  0.766
2001 Snyder SE, Gunupudi N, Sherman PS, Butch ER, Skaddan MB, Kilbourn MR, Koeppe RA, Kuhl DE. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 132-43. PMID 11176278 DOI: 10.1097/00004647-200102000-00004  0.772
2001 Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse (New York, N.Y.). 39: 275-87. PMID 11169777 DOI: 10.1002/1098-2396(20010315)39:4<275::Aid-Syn1010>3.0.Co;2-3  0.386
2001 Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry. 49: 110-6. PMID 11164757 DOI: 10.1016/S0006-3223(00)00981-1  0.319
2001 Skaddan MB, Jewett DM, Kilbourn MR, Sherman PS. The synthesis, 11C-labeling, and biological evaluation of (R)-N-[11C]methyl-3-pyrrolidyl benzilate as an acetylcholine-sensitive ligand for the muscarinic acetylcholine receptor Journal of Labelled Compounds and Radiopharmaceuticals. 44: S24-S25. DOI: 10.1002/Jlcr.2580440109  0.752
2000 Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS, Desmond TJ, Frey KA. Synthesis, 18F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors Journal of Medicinal Chemistry. 43: 4552-4562. PMID 11087580 DOI: 10.1021/Jm000305O  0.783
2000 Zubieta J, Greenwald MK, Lombardi U, Woods JH, Kilbourn MR, Jewett DM, Koeppe RA, Schuster CR, Johanson CE. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 326-34. PMID 10942856 DOI: 10.1016/S0893-133X(00)00110-X  0.478
2000 Brown-Proctor C, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and in vivo evaluation of (E)-N-[11C]methyl-4(3-pyridinyl)-3-butene-l-amine ([11C]metanicotine) as a nicotinic receptor radioligand Nuclear Medicine and Biology. 27: 415-418. PMID 10938478 DOI: 10.1016/S0969-8051(00)00091-3  0.814
2000 Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780 DOI: 10.1212/Wnl.54.9.1753  0.343
2000 Kilbourn MR, Kuszpit K, Sherman P. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice Synapse. 35: 250-255. PMID 10657034 DOI: 10.1002/(Sici)1098-2396(20000315)35:4<250::Aid-Syn2>3.0.Co;2-S  0.35
2000 Brown-Proctor C, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and in vivo evaluation of (E)-N-[11C]Methyl-4-(3-pyridinyl)-3-butene-1-amine ([11C]metanicotine) as a nicotinic receptor radioligand Journal of Inorganic Biochemistry. 78: 415-418.  0.796
1999 Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1376-84. PMID 10598942 DOI: 10.1097/00004647-199912000-00011  0.411
1999 Koeppe RA, Frey KA, Snyder SE, Meyer P, Kilbourn MR, Kuhl DE. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1150-63. PMID 10532640 DOI: 10.1097/00004647-199910000-00012  0.356
1999 Kilbourn MR, Sherman PS, Snyder SE. Simplified methods for in vivo measurement of acetylcholinesterase activity in rodent brain Nuclear Medicine and Biology. 26: 543-550. PMID 10473193 DOI: 10.1016/S0969-8051(98)00122-X  0.388
1999 Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428 DOI: 10.1212/Wnl.53.2.371  0.347
1999 Brown-Proctor C, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and evaluation of 6-[11C]methoxy-3-[2[1-(phenylmethyl)-4- piperidinyl]ethyl]-1,2-benzisoxazole as an in vivo radioligand for acetylcholinesterase Nuclear Medicine and Biology. 26: 99-103. PMID 10096508 DOI: 10.1016/S0969-8051(98)00078-X  0.821
1999 Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 52: 691-9. PMID 10078712 DOI: 10.1212/Wnl.52.4.691  0.344
1999 Snyder SE, Sherman PS, Desmond TJ, Frey KA, Kilbourn MR. (-)-6',7'-[11C]dihydroroten-12α-ol ((-)-[11C]DHROL) for in vivo measurement of mitochondrial complex I Journal of Labelled Compounds and Radiopharmaceuticals. 42: 641-652. DOI: 10.1002/(Sici)1099-1344(199907)42:7<641::Aid-Jlcr226>3.0.Co;2-Y  0.421
1998 Nguyen TB, Snyder SE, Kilbourn MR. Syntheses of carbon-11 labeled piperidine esters as potential in vivo substrates for acetylcholinesterase Nuclear Medicine and Biology. 25: 761-768. PMID 9863564 DOI: 10.1016/S0969-8051(98)00072-9  0.381
1998 Snyder SE, Tluczek L, Jewett DM, Nguyen TB, Kuhl DE, Kilbourn MR. Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nuclear Medicine and Biology. 25: 751-4. PMID 9863562 DOI: 10.1016/S0969-8051(98)00045-6  0.411
1998 Mulholland GK, Wieland DM, Kilbourn MR, Frey KA, Sherman PS, Carey JE, Kuhl DE. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (New York, N.Y.). 30: 263-74. PMID 9776130 DOI: 10.1002/(Sici)1098-2396(199811)30:3<263::Aid-Syn4>3.0.Co;2-9  0.486
1998 Frey KA, Wieland DM, Kilbourn MR. Imaging of monoaminergic and cholinergic vesicular transporters in the brain Advances in Pharmacology (San Diego, Calif.). 42: 269-272. PMID 9327896 DOI: 10.1016/S1054-3589(08)60745-0  0.377
1997 Kilbourn MR. In vivo radiotracers for vesicular neurotransmitter transporters Nuclear Medicine and Biology. 24: 615-619. PMID 9352531 DOI: 10.1016/S0969-8051(97)00101-7  0.332
1997 Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 919-31. PMID 9307605 DOI: 10.1097/00004647-199709000-00001  0.338
1997 Kilbourn M, Sherman P. In vivo binding of (+)-alpha-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies. European Journal of Pharmacology. 331: 161-8. PMID 9274975 DOI: 10.1016/S0014-2999(97)01054-6  0.352
1997 Kilbourn MR, Charalambous A, Frey KA, Sherman P, Higgins DS, Greenamyre JT. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 265-72. PMID 9119899 DOI: 10.1097/00004647-199703000-00003  0.355
1997 Jewett DM, Kilbourn MR, Lee LC. A simple synthesis of [11C]dihydrotetrabenazine (DTBZ) Nuclear Medicine and Biology. 24: 197-199. PMID 9089713 DOI: 10.1016/S0969-8051(96)00213-2  0.337
1997 Kilbourn MR. Time-dependent recovery of in vivo binding sites after drug dosing: A method for radiotracer evaluation Nuclear Medicine and Biology. 24: 115-118. PMID 9080483 DOI: 10.1016/S0969-8051(96)00179-5  0.334
1997 Kilbourn M, Frey K. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains. European Journal of Pharmacology. 307: 227-32. PMID 8832225 DOI: 10.1016/0014-2999(96)00252-X  0.309
1996 Gilman S, Frey KA, Koeppe RA, Junck L, Little R, Vander Borght TM, Lohman M, Martorello S, Lee LC, Jewett DM, Kilbourn MR. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Annals of Neurology. 40: 885-92. PMID 9007093 DOI: 10.1002/Ana.410400610  0.334
1996 Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/Ana.410400609  0.37
1996 Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 1288-99. PMID 8898703 DOI: 10.1097/00004647-199611000-00025  0.302
1996 Bormans G, Sherman P, Snyder SE, Kilbourn MR. Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4'-fluorobenzoate and their biodistribution in mice. Nuclear Medicine and Biology. 23: 513-7. PMID 8832709 DOI: 10.1016/0969-8051(96)00033-9  0.608
1996 Kilbourn MR, Frey KA, Vander Borght T, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters Nuclear Medicine and Biology. 23: 467-471. PMID 8832701 DOI: 10.1016/0969-8051(96)00023-6  0.354
1996 Kilbourn MR, Snyder SE, Sherman PS, Kuhl DE. In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). Synapse (New York, N.Y.). 22: 123-31. PMID 8787128 DOI: 10.1002/(Sici)1098-2396(199602)22:2<123::Aid-Syn5>3.0.Co;2-F  0.451
1996 Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 409-17. PMID 8621745 DOI: 10.1097/00004647-199605000-00007  0.353
1996 Lee LC, Borght TV, Sherman PS, Frey KA, Kilbourn MR. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter Journal of Medicinal Chemistry. 39: 191-196. PMID 8568807 DOI: 10.1021/Jm950117B  0.412
1995 Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience. 68: 955-62. PMID 8577387 DOI: 10.1016/0306-4522(95)00167-H  0.309
1995 Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA. In vivo imaging of the brain vesicular monoamine transporter. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 2252-60. PMID 8523116  0.326
1995 Van Dort ME, Jung YW, Sherman PS, Kilbourn MR, Wieland DM. Fluorine for hydroxy substitution in biogenic amines: Asymmetric synthesis and biological evaluation of fluorine-18-labeled β-fluorophenylalkylamines as model systems Journal of Medicinal Chemistry. 38: 810-815. PMID 7877146 DOI: 10.1021/Jm00005A008  0.462
1995 Charalambous A, Mangner TJ, Kilbourn MR. Synthesis of (2-[11C]methoxy)rotenone, a marker of mitochondrial complex I activity Nuclear Medicine and Biology. 22: 65-69. PMID 7735172 DOI: 10.1016/0969-8051(94)00075-U  0.326
1995 Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE. Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nuclear Medicine and Biology. 22: 13-7. PMID 7735163 DOI: 10.1016/0969-8051(94)00082-U  0.447
1995 Snyder SE, Kume A, Jung YW, Connor SE, Sherman PS, Albin RL, Wieland DM, Kilbourn MR. Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxides. Journal of Medicinal Chemistry. 38: 2663-71. PMID 7629805 DOI: 10.1021/Jm00014A018  0.491
1995 Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. European Journal of Pharmacology. 278: 249-52. PMID 7589162 DOI: 10.1016/0014-2999(95)00162-E  0.331
1995 Kilbourn MR, Sherman PS, Abbott LC. Mutant mouse strains as models for in vivo radiotracer evaluations: [11C]methoxytetrabenazine ([11C]MTBZ) in Tottering mice Nuclear Medicine and Biology. 22: 565-567. PMID 7581164 DOI: 10.1016/0969-8051(95)00005-I  0.395
1995 Charalambous A, Tluczek L, Frey KA, Higgins DS, Greenamyre TJ, Kilbourn MR. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nuclear Medicine and Biology. 22: 491-6. PMID 7550026 DOI: 10.1016/0969-8051(94)00129-8  0.403
1995 Bormans G, Kilbourn MR. Synthesis of N-tert-butyl-α-(4−[18F]fluorophenyl)-nitrone ([18F]FPBN) for in vivo detection of free radicals Journal of Labelled Compounds and Radiopharmaceuticals. 36: 103-110. DOI: 10.1002/Jlcr.2580360202  0.581
1994 Dasilva JN, Carey JE, Sherman PS, Pisani TJ, Kilbourn MR. Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter Nuclear Medicine and Biology. 21: 151-156. PMID 9234277 DOI: 10.1016/0969-8051(94)90003-5  0.671
1994 Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee KS, Kuhl DE. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 85-99. PMID 8263062 DOI: 10.1038/Jcbfm.1994.13  0.384
1994 Kilbourn MR. [11C]NNC 12-0722 or [18F]GBR 13119: Just what is "better"? European Journal of Nuclear Medicine. 21: 695. PMID 7957357 DOI: 10.1007/Bf00285593  0.421
1994 Charalambous A, Mangner TJ, Kilbourn MR. Synthesis of (N-[11C]methyl)Y-29794, a competitive inhibitor of prolyl endopeptidase Journal of Labelled Compounds and Radiopharmaceuticals. 34: 499-504. DOI: 10.1002/Jlcr.2580340602  0.402
1994 Van Dort ME, Kilbourn MR, Mangner TJ. Synthesis of N-{N-[4-(4-{N 11C]methylamino}phenyl)butyryl]-L-prolyl}pyrrolidine: A potential radiotracer for prolyl endopeptidase Journal of Labelled Compounds and Radiopharmaceuticals. 34: 447-452. DOI: 10.1002/Jlcr.2580340507  0.378
1993 Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography. Journal of Neurochemistry. 60: 2315-8. PMID 8492135 DOI: 10.1111/J.1471-4159.1993.Tb03521.X  0.66
1993 DaSilva JN, Kilbourn MR, Mangner TJ. Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies Applied Radiation and Isotopes. 44: 673-676. PMID 8472029 DOI: 10.1016/0969-8043(93)90130-3  0.658
1993 DaSilva JN, Kilbourn MR, Domino EF. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine. Synapse (New York, N.Y.). 14: 128-31. PMID 8332945 DOI: 10.1002/Syn.890140205  0.674
1993 Chakraborty PK, Gildersleeve DL, Jewett DM, Toorongian SA, Kilbourn MR, Schwaiger M, Wieland DM. High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans Nuclear Medicine and Biology. 20: 939-944. PMID 8298573 DOI: 10.1016/0969-8051(93)90094-B  0.376
1993 DaSilva JN, Kilbourn MR, Mangner TJ. Synthesis of a [11C]Methoxy derivative of α-Dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter Applied Radiation and Isotopes. 44: 1487-1489. PMID 7903060 DOI: 10.1016/0969-8043(93)90103-H  0.62
1993 Mulholland GK, Jung YW, Wieland DM, Kilbourn MR, Kuhl DE. Synthesis of [18F]fluoroethoxy-benzovesamicol, A radiotracer for cholinergic neurons Journal of Labelled Compounds and Radiopharmaceuticals. 33: 583-591. DOI: 10.1002/Jlcr.2580330704  0.409
1993 Rengan R, Chakraborty PK, Kilbourn MR. Can we predict reactivity for aromatic nucleophilic substitution with [18F]fluoride ion? Journal of Labelled Compounds and Radiopharmaceuticals. 33: 563-572. DOI: 10.1002/Jlcr.2580330702  0.329
1993 Hasan A, Knapp FF, Kilbourn MR, Buchsbaum DJ. New azomycin acyclonucleoside. Synthesis and biodistribution of radiohalogenated analogues in tumor-bearing mice †‡ Journal of Heterocyclic Chemistry. 30: 1351-1355. DOI: 10.1002/Jhet.5570300528  0.328
1992 Mulholland GK, Otto CA, Jewett DM, Kilbourn MR, Koeppe RA, Sherman PS, Petry NA, Carey JE, Atkinson ER, Archer S. Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 33: 423-30. PMID 1740713  0.379
1992 DaSilva JN, Kilbourn MR. In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain Life Sciences. 51: 593-600. PMID 1640810 DOI: 10.1016/0024-3205(92)90228-H  0.646
1992 Daugherty A, Kilbourn MR, Dence CS, Sobel BE, Thorpe SR. Quantitative assessment of lipoprotein metabolism by positron emission tomography with an 18F-containing residualizing label Nuclear Medicine and Biology. 19: 411-416. PMID 1629030 DOI: 10.1016/0883-2897(92)90127-K  0.428
1992 Kilbourn MR, Sherman PS, Pisani T. Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site European Journal of Pharmacology. 216: 109-112. PMID 1526249 DOI: 10.1016/0014-2999(92)90216-Q  0.423
1992 Van Dort ME, Kilbourn MR, Chakraborty PK, Richfield EK, Gildersleeve DL, Wieland DM. Iodine-125 and fluorine-18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals for in vivo study of the dopamine uptake system. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 43: 671-80. PMID 1325425 DOI: 10.1016/0883-2889(92)90039-H  0.421
1991 Otsuka FL, Welch MJ, Kilbourn MR, Dence CS, Dilley WG, Wells SA. Antibody fragments labeled with fluorine-18 and gallium-68: In vivo comparison with indium-111 and iodine-125-labeled fragments Nuclear Medicine and Biology. 18: 813-816. PMID 1787093 DOI: 10.1016/0883-2897(91)90023-E  0.506
1991 Kilbourn MR, Mulholland GK, Sherman PS, Pisani T. In vivo binding of the dopamine uptake inhibitor [18F]GBR 13119 in MPTP-treated C57BL/6 mice Nuclear Medicine and Biology. 18: 803-806. PMID 1787091 DOI: 10.1016/0883-2897(91)90021-C  0.421
1991 Chakraborty PK, Kilbourn MR. [18F]fluorination/decarbonylation: New route to aryl [18F]fluorides International Journal of Radiation Applications and Instrumentation. Part. 42: 1209-1213. PMID 1668803 DOI: 10.1016/0883-2889(91)90199-B  0.41
1991 Chakraborty PK, Kilbourn MR. Oxidation of substituted 4-fluorobenzaldehydes: Application to the no-carrier-added syntheses of 4-[18F]fluoroguaiacol and 4-[18F]fluorocatechol International Journal of Radiation Applications and Instrumentation. Part. 42: 673-681. PMID 1663098 DOI: 10.1016/0883-2889(91)90039-4  0.408
1991 Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Annals of Neurology. 30: 663-72. PMID 1662476 DOI: 10.1002/Ana.410300506  0.403
1991 Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 735-44. PMID 1651944 DOI: 10.1038/Jcbfm.1991.130  0.381
1991 Kilbourn MR. Synthesis of [18F]flunarizine International Journal of Radiation Applications and Instrumentation. Part. 42: 109-111. PMID 1648032 DOI: 10.1016/0883-2889(91)90058-9  0.408
1990 Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR. Routine production of 2-Deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin Nuclear Medicine and Biology. 17: 273-279. PMID 2341282 DOI: 10.1016/0883-2897(90)90052-3  0.397
1990 Kilbourn MR, Jung YW, Haka MS, Gildersleeve DL, Kuhl DE, Wieland DM. Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sciences. 47: 1955-63. PMID 2266779 DOI: 10.1016/0024-3205(90)90408-J  0.391
1990 Kilbourn MR, Pavia MR, Gregor VE. Synthesis of fluorine-18 labeled GABA uptake inhibitors International Journal of Radiation Applications and Instrumentation. Part. 41: 823-828. PMID 2176190 DOI: 10.1016/0883-2889(90)90059-P  0.418
1990 Jewett DM, Toorongian SA, Bachelor MA, Kilbourn MR. Extraction of [18F]fluoride from [18O]water by a fast fibrous anion exchange resin International Journal of Radiation Applications and Instrumentation. Part. 41: 583-586. PMID 2163375 DOI: 10.1016/0883-2889(90)90044-H  0.318
1990 Ciliax BJ, Kilbourn MR, Haka MS, Penney JB. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain. Journal of Neurochemistry. 55: 619-23. PMID 2115074 DOI: 10.1111/J.1471-4159.1990.Tb04178.X  0.4
1990 Mulholland GK, Kilbourn MR, Moskwa JJ. Direct simultaneous production of [15O]water and [13N]ammonia or [18F]fluoride ion by 26 MeV proton irradiation of a double chamber water target International Journal of Radiation Applications and Instrumentation. Part. 41: 1193-1199. PMID 1963419 DOI: 10.1016/0883-2889(90)90206-V  0.314
1990 Kilbourn MR, Subramanian R. Synthesis of fluorine-18 labeled 1,1-difluoro-2,2-dichloroethyl aryl ethers by 18F-for-19F exchange Journal of Labelled Compounds and Radiopharmaceuticals. 28: 1355-1361. DOI: 10.1002/Jlcr.2580281202  0.369
1990 Haka MS, Kilbourn MR. Synthesis of [18F]GBR 12909, a dopamine reuptake inhibitor Journal of Labelled Compounds and Radiopharmaceuticals. 28: 793-799. DOI: 10.1002/Jlcr.2580280708  0.425
1989 Perlmutter JS, Kilbourn MR, Welch MJ, Raichle ME. Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 2344-52. PMID 2787394 DOI: 10.1523/Jneurosci.09-07-02344.1989  0.484
1989 Kilbourn MR. Thiophenes as phenyl bio-isosteres: Application in radiopharmaceutical design. I. Dopamine uptake antagonists Nuclear Medicine and Biology. 16: 681-686. PMID 2613523 DOI: 10.1016/0883-2897(89)90138-4  0.458
1989 Kilbourn MR, Carey JE, Koeppe RA, Haka MS, Hutchins GD, Sherman PS, Kuhl DE. Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 16: 569-76. PMID 2606712 DOI: 10.1016/0883-2897(89)90072-X  0.472
1989 Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, McKeever PE, Wieland DM, Kilbourn MR, Starosta-Rubinstein S. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Annals of Neurology. 26: 752-8. PMID 2557794 DOI: 10.1002/Ana.410260611  0.406
1989 Haka MS, Kilbourn MR. Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 16: 771-4. PMID 2533589 DOI: 10.1016/0883-2897(89)90160-8  0.448
1989 Kilbourn MR, Haka MS, Mulholland GK, Sherman PS, Pisani T. Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 mice. European Journal of Pharmacology. 166: 331-4. PMID 2529129 DOI: 10.1016/0014-2999(89)90078-2  0.399
1989 Haka MS, Kilbourn MR, Watkins GL, Toorongian SA. Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR-13119 Journal of Labelled Compounds and Radiopharmaceuticals. 27: 823-833. DOI: 10.1002/Jlcr.2580270711  0.425
1989 Kilbourn MR, Haka, Mulholland GK, Jewett DM, Kuhl DE. Synthesis of radiolabeled inhibitors of presynaptic monoamine uptake systems; [18F]GBR 13119 (DA),[11C]nisoxetine (NE), and [11C]fluoxetine (5-HT) Journal of Labelled Compounds and Radiopharmaceuticals. 26: 412-414. DOI: 10.1002/Jlcr.25802601177  0.372
1989 Mulholland GK, Mangner TJ, Jewett DM, Kilbourn MR. Polymer-supported nucleophilic radiolabeling reactions with [18F]fluoride and [11C]cyanide ion on quaternary ammonium resins Journal of Labelled Compounds and Radiopharmaceuticals. 26: 378-380. DOI: 10.1002/Jlcr.25802601162  0.307
1989 Van Dort M, Yang D, Kilbourn M, Gole D, Kalir A, Domino E, Young A, Wieland D. Synthesis of [18F]phencyclidines for glutamate receptor mapping Journal of Labelled Compounds and Radiopharmaceuticals. 26: 346-347. DOI: 10.1002/Jlcr.25802601150  0.427
1989 Haka M, Kilbourn M, Watkins G. Aryl trimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides Journal of Labelled Compounds and Radiopharmaceuticals. 26: 17-19. DOI: 10.1002/Jlcr.2580260109  0.389
1989 Wieland D, Kilbourn M, Laborde E, Yang D, Pirat J, Gildersleeve D, Van Dort M, Ciliax B, Young A. Happing cation channels: Synthesis of [125I] and [18F] analogs of MK-801 Journal of Labelled Compounds and Radiopharmaceuticals. 26: 10-11. DOI: 10.1002/Jlcr.2580260106  0.346
1988 Kilbourn MR. In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system Life Sciences. 42: 1347-1353. PMID 3352457 DOI: 10.1016/0024-3205(88)90163-4  0.457
1988 Welch MJ, Katzenellenbogen JA, Mathias CJ, Brodack JW, Carlson KE, Chi DY, Dence CS, Kilbourn MR, Perlmutter JS, Raichle ME. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 15: 83-97. PMID 3258305 DOI: 10.1016/0883-2897(88)90164-X  0.748
1988 Wieland DM, Kilbourn MR, Yang DJ, Laborde E, Gildersleeve DL, Van Dort ME, Pirat JL, Ciliax BJ, Young AB. NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 39: 1219-25. PMID 2851002 DOI: 10.1016/0883-2889(88)90103-7  0.418
1988 Jewett DM, Toorongian SA, Mulholland GK, Watkins GL, Kilbourn MR. Multiphase extraction: Rapid phase-transfer of [18F]fluoride ion for nucleophilic radiolabeling reactions International Journal of Radiation Applications and Instrumentation. Part. 39: 1109-1111. PMID 2850283 DOI: 10.1016/0883-2889(88)90001-9  0.326
1988 Brodack JW, Dence CS, Kilbourn MR, Welch MJ. Robotic production of 2-deoxy-2[18F]fluoro-d-glucose: A routine method of synthesis using tetrabutylammonium [18F]fluoride International Journal of Radiation Applications and Instrumentation. Part. 39: 699-703. PMID 2844702 DOI: 10.1016/0883-2889(88)90060-3  0.53
1988 Brodack JW, Kilbourn MR, Welch MJ. Automated production of several positron-emitting radiopharmaceuticals using a single laboratory robot International Journal of Radiation Applications and Instrumentation. Part. 39: 689-698. PMID 2844701 DOI: 10.1016/0883-2889(88)90059-7  0.496
1988 Kilbourn MR, Haka MS. Synthesis of [18F]GBR13119, a presynaptic dopamine uptake antagonist. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 39: 279-82. PMID 2838432 DOI: 10.1016/0883-2889(88)90015-9  0.426
1988 Leonard Watkins G, Jewett DM, Keith Mulholland G, Kilbourn MR, Toorongian SA. A captive solvent method for rapid N-[11C]methylation of secondary amides: Application to the benzodiazepine, 4′-chlorodiazepam (RO5-4864) International Journal of Radiation Applications and Instrumentation. Part. 39: 441-444. DOI: 10.1016/0883-2889(88)90077-9  0.37
1987 Welch MJ, Chi DY, Mathias CJ, Kilbourn MR, Brodack JW, Katzenellenbogen JA. Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 13: 523-6. PMID 3818316 DOI: 10.1016/0883-2897(86)90132-7  0.728
1987 Mathias CJ, Welch MJ, Kilbourn MR, Jerabek PA, Patrick TB, Raichle ME, Krohn KA, Rasey JS, Shaw DW. Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. Life Sciences. 41: 199-206. PMID 3600179 DOI: 10.1016/0024-3205(87)90494-2  0.507
1987 Perlmutter JS, Kilbourn MR, Raichle ME, Welch MJ. MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology. 37: 1575-9. PMID 3498914 DOI: 10.1212/Wnl.37.10.1575  0.567
1987 Herscovitch P, Raichle ME, Kilbourn MR, Welch MJ. Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 527-42. PMID 3498732 DOI: 10.1038/Jcbfm.1987.102  0.502
1987 Mathias CJ, Welch MJ, Katzenellenbogen JA, Brodack JW, Kilbourn MR, Carlson KE, Kiesewetter DO. Characterization of the uptake of 16α-([18F]fluoro)-17β-estradiol in DMBA-induced mammary tumors Nuclear Medicine and Biology. 14: 15-25. PMID 3108199 DOI: 10.1016/0883-2897(87)90156-5  0.598
1987 Chi DY, Kilbourn MR, Katzenellenbogen JA, Brodack JW, Welch MJ. Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 1173-80. PMID 3028983 DOI: 10.1016/0883-2889(86)90002-X  0.73
1987 Dae YC, Kilbourn MR, Katzenellenbogen JA, Welch MJ. A rapid and efficient method for the fluoroalkylation of amines and amides. Development of a method suitable for incorporation of the short-lived positron emitting radionuclide fluorine-18 Journal of Organic Chemistry. 52: 658-664. DOI: 10.1021/Jo00380A030  0.543
1986 Jerabek PA, Dence CS, Kilbourn MR, Welch MJ, Kadmon D. Synthesis and uptake of no-carrier-added 1-[11C]putrescine into rat prostate. International Journal of Nuclear Medicine and Biology. 12: 349-52. PMID 3833820 DOI: 10.1016/S0047-0740(85)80002-4  0.469
1986 Perlmutter JS, Larson KB, Raichle ME, Markham J, Mintun MA, Kilbourn MR, Welch MJ. Strategies for in vivo measurement of receptor binding using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 6: 154-69. PMID 3485640 DOI: 10.1038/Jcbfm.1986.29  0.523
1986 Hwang DR, Jerabek PA, Kadmon D, Kilbourn MR, Patrick TB, Welch MJ. 2-[18F]fluoroputrescine: preparation, biodistribution, and mechanism of defluorination. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 607-12. PMID 3021663 DOI: 10.1016/0883-2889(86)90080-8  0.547
1986 Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ. Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 599-605. PMID 3021662 DOI: 10.1016/0883-2889(86)90079-1  0.573
1986 Brodack JW, Kilbourn MR, Welch MJ, Katzenellenbogen JA. NCA 16 alpha-[18F]fluoroestradiol-17 beta: the effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 217-21. PMID 3019933 DOI: 10.1016/0883-2889(86)90174-7  0.609
1986 Kilbourn MR, Welch MJ. Fluorine-18 labeled receptor based radiopharmaceuticals. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 677-83. PMID 2876971 DOI: 10.1016/0883-2889(86)90261-3  0.458
1986 Patrick TB, Johri KK, White DH, Bertrand WS, Mokhtar R, Kilbourn MR, Welch MJ. Replacement of the carboxylic acid function with fluorine Canadian Journal of Chemistry. 64: 138-141. DOI: 10.1139/V86-024  0.412
1986 Dae YC, Kiesewetter DO, Katzenellenbogen JA, Kilbourn MR, Welch MJ. Halofluorination of olefins: elucidation of reaction characteristics and applications in labeling with the positron-emitting radionuclide fluorine-18 Journal of Fluorine Chemistry. 31: 99-113. DOI: 10.1016/S0022-1139(00)85091-5  0.555
1986 Welch MJ, Kilbourn MR. Potential Labeling of Monoclonal Antibodies with Positron Emitters International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 13: 261-267. DOI: 10.1007/978-1-4684-5538-0_20  0.483
1985 Kilbourn MR, Jerabek PA, Welch MJ. An improved [18O]water target for [18F]fluoride production. The International Journal of Applied Radiation and Isotopes. 36: 327-8. PMID 4018895 DOI: 10.1016/0020-708X(85)90099-7  0.472
1985 Welch MJ, Kilbourn MR, Green MA. Radiopharmaceuticals labeled with short-lived positron-emitting radionuclides. Radioisotopes. 34: 170-9. PMID 3892598 DOI: 10.3769/Radioisotopes.34.3_170  0.459
1985 Welch MJ, Kilbourn MR. A remote system for the routine production of oxygen‐15 radiopharmaceuticals Journal of Labelled Compounds and Radiopharmaceuticals. 22: 1193-1200. DOI: 10.1002/Jlcr.2580221114  0.448
1984 Welch MJ, Raichle ME, Kilbourn MR, Mintun MA. [18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor. Annals of Neurology. 15: S77-8. PMID 6611130 DOI: 10.1002/Ana.410150714  0.522
1984 Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Annals of Neurology. 15: 217-27. PMID 6609679 DOI: 10.1002/Ana.410150302  0.554
1984 Kilbourn MR, Dischino DD, Welch MJ. Synthesis of DL-[3-11C]phenylalanine. The International Journal of Applied Radiation and Isotopes. 35: 603-5. PMID 6469391 DOI: 10.1016/0020-708X(84)90103-0  0.502
1984 Kilbourn MR, Hood JT, Welch MJ. A simple 18O water target for 18F production. The International Journal of Applied Radiation and Isotopes. 35: 599-602. PMID 6469390 DOI: 10.1016/0020-708X(84)90102-9  0.496
1984 Kilbourn MR, Welch MJ, Dence CS, Tewson TJ, Saji H, Maeda M. Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol. The International Journal of Applied Radiation and Isotopes. 35: 591-8. PMID 6469389 DOI: 10.1016/0020-708X(84)90101-7  0.523
1984 Landvatter SW, Kiesewetter DO, Kilbourn MR, Katzenellenbogen JA, Welch MJ. (2R*, 3S*)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)pentane [( 18F]fluoronor-hexestrol), a positron-emitting estrogen that shows highly-selective, receptor-mediated uptake by target tissues in vivo. Life Sciences. 33: 1933-8. PMID 6316052 DOI: 10.1016/0024-3205(83)90678-1  0.65
1984 Kiesewetter DO, Katzenellenbogen JA, Kilbourn MR, Welch MJ. Synthesis of 16-fluoroestrogens by unusually facile fluoride ion displacement reactions: prospects for the preparation of fluorine-18 labeled estrogens The Journal of Organic Chemistry. 49: 4900-4905. DOI: 10.1021/Jo00199A031  0.557
1984 Dence CS, Lechner KA, Welch MJ, Kilbourn MR. Remote system for production of carbon‐11 labeled glucose via photosynthesis Journal of Labelled Compounds and Radiopharmaceuticals. 21: 743-750. DOI: 10.1002/Jlcr.2580210808  0.435
1983 Welch MJ, Kilbourn MR, Mathias CJ, Mintun MA, Raichle ME. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. Life Sciences. 33: 1687-93. PMID 6633162 DOI: 10.1016/0024-3205(83)90725-7  0.571
1983 Kilbourn MR, Jerabek PA, Welch MJ. Synthesis of carbon-11 labelled amides via carbonylation of lithium dialkylamides Journal of the Chemical Society, Chemical Communications. 861-862. DOI: 10.1039/C39830000861  0.426
1983 Welch MJ, Dence CS, Marshall DR, Kilbourn MR. Remote system for production of carbon-11 labeled palmitic acid Journal of Labelled Compounds and Radiopharmaceuticals. 20: 1087-1095. DOI: 10.1002/Jlcr.2580200906  0.451
1982 Kilbourn MR, McElvany KD, Welch MJ. A simple synthesis of bromine-77-labeled alkyl bromides. The International Journal of Applied Radiation and Isotopes. 33: 391-2. PMID 7095878 DOI: 10.1016/0020-708X(82)90156-9  0.447
1982 Kilbourn MR, Welch MJ. No-carrier-added synthesis of [1-11C]pyruvic acid. The International Journal of Applied Radiation and Isotopes. 33: 359-61. PMID 7095876 DOI: 10.1016/0020-708X(82)90149-1  0.468
1982 Kilbourn MR, Dischino DD, Dence CS, Welch MJ. SEP-PAK Preparative Chromatography: Use in Radiopharmaceutical Synthesis Journal of Liquid Chromatography & Related Technologies. 5: 2005-2016. DOI: 10.1080/01483918208062869  0.503
1982 Kilbourn MR, Welch MJ. New methods of radiobromination. The sodium [77Br]bromide/tetrahalomethane/ triphenylphosphine reagent system The International Journal of Applied Radiation and Isotopes. 33: 1479-1480. DOI: 10.1016/0020-708X(82)90193-4  0.437
1981 Ng JS, Katzenellenbogen JA, Kilbourn MR. Aromatic fluorinations suitable for fluorine-18 labeling of estrogens The Journal of Organic Chemistry. 46: 2520-2528. DOI: 10.1021/Jo00325A017  0.447
1981 Goswami R, Kilbourn MR, Katzenellenbogen JA. 1-dehydrohexestrol. Synthesis of a precursor for the preparation of tritium-labeled hexestrol derivatives and its use in a new, convenient synthesis of tritium-labeled o-azido-hexestrol Journal of Labelled Compounds and Radiopharmaceuticals. 18: 407-418. DOI: 10.1002/Jlcr.2580180315  0.46
1980 Katzenellenbogen JA, Kilbourn MR, Carlson KE. Photosensitive steroids as probes of estrogen receptor sites. Annals of the New York Academy of Sciences. 346: 18-30. PMID 6930181 DOI: 10.1111/J.1749-6632.1980.Tb22088.X  0.429
Show low-probability matches.